![]() |
인쇄하기
취소
|
The 11th new drug developed by a local drug company may be introduced soon but the marketability of those new drugs has not made any progress at all. 7 in 10 new drugs in Korea showed less than 2 billion won of annual NHI reimbursement.
According to "2005 EDI bills of new drugs developed by Korea" reported by the Health Insurance Review Agency (HIRA), the total number of Korean new drugs...